Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benmelstobart and Radiotherapy Fractionation in Metastatic NSCLC
NCT06953843Phase 2Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of benmelstobart in non-small cell lung cancer (NSCLC), sponsored by Xinqiao Hospital. Started Jul 2025; status: recruiting.
02
Drugs
benmelstobart
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06953843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06953843.